Abstract: Methods for stabilizing ?-galactosidase, stabilizing ?-glucocerebrosidase, treating a glycolipid metabolic disorder caused by mutation of ?-galactosidase gene, treating a glycolipid metabolic disorder caused by mutation of ?-glucocerebrosidase gene, regenerating the activity of ?-galactosidase, regenerating the activity of ?-glucosidase, treating GM1 gangliosidosis, Morquio-B or Krabbe's disease, and treating Gaucher's disease, include administering a carba-sugar amine derivative represented by the following formula (1) or (2):

Abstract: A carba-sugar amine derivative represented by the following formula (1) or (2) is used as the active ingredient of a ?-galactosidase inhibitor or a glycolipid metabolic disorder treating agent. Wherein each of R1 and R2 independently represents H, an alkyl group, an acyl group, an aryl group or an aralkyl group, with the proviso that both are not H at the same time, and each of R3, R4, R5 and R6 independently represents a hydroxyl group or hydroxyl group having a substituent. Also, R7 represents an alkyl group, and each of R8, R9, R10 and R11 independently represents a hydroxyl group or a hydroxyl group having a substituent.

Abstract: A carba-sugar amine derivative represented by the following formula (1) or (2) is used as the active ingredient of a ?-galactosidase inhibitor or a glycolipid metabolic disorder treating agent. Wherein each of R1 and R2 independently represents H, an alkyl group, an acyl group, an aryl group or an aralkyl group, with the proviso that both are not H at the same time, and each of R3, R4, R5 and R6 independently represents a hydroxyl group or hydroxyl group having a substituent. Also, R7 represents an alkyl group, and each of R8, R9, R10 and R11 independently represents a hydroxyl group or a hydroxyl group having a substituent.

Abstract: A carba-sugar amine derivative represented by the following formula (1) or (2) is used as the active ingredient of a &bgr;-galactosidase inhibitor or a glycolipid metabolic disorder treating agent.

Abstract: The present invention provides a compound which is a glycolipid analog having a novel structure represented by the formula (1): ##STR1## wherein Z represents an imino group, an oxygen atom or a sulfur atom; m is an integer of from 3 to 12; and n is an integer of from 4 to 22; and shows a potent activity of inhibiting glycosidase and has potential physiological activities, for example, antiviral activity. The invention also provides a glycosidase inhibitor which comprises said glycolipid analog as an active ingredient.

Abstract: The present invention provides aminocyclopentane derivatives which are saccharide analogs having extremely high .alpha.-glucosidase inhibitory effects and novel structures and expected to be usable or applicable to drugs or agricultural chemicals. An aminocyclopentane derivative represented by the formula (1), wherein R.sub.1 represents H while R.sub.2 represents CH.sub.2 OH, or R.sub.1 represents CH.sub.2 OH while R.sub.2 represents H and R.sub.3 represents a substituted or unsubstituted aryl group or an alkyl, alkenyl, alkynyl or hydroxyalkyl group having 1 to 10 carbon atoms, intermediates for the synthesis of the same, a process for producing the intermediates and a process for producing the aminocyclopentane derivative.

Abstract: Inositol compounds grouped into an aminocyclitol family are disclosed which have stereospecific structure and optical activity and find application to the manufacture of medicinal products and agricultural chemicals. The compound is produced with use of optically active L-quebrachitol as a starting material and by way of specific steps of reaction.

Abstract: Purified L-quebrachitol is recovered in increased quantities from rubber latex by dissolving concentrated solutions or pulverized solids of the serums in methyl alcohol under specified extraction conditions.

Abstract: An arithmetic logic unit for a stored program sequence controller stores a program equivalent to a relay sequence in a program memory and executes sequence control in accordance with the stored program. A first push-down storage register for sequentially storing logical operation results at branch start points of the relay sequence and a second push-down storage register for sequentially storing logical operation results for branches connected to the branch points based on the logical operation results stored in the first push-down storage register are provided. The arithmetic logic unit carries out the operations based on the logical operation results stored in the first and second push-down storage registers.

Abstract: Disclosed is a signal transmitting and receiving apparatus for transmitting and receiving parallel-by-word data signals, converting the parallel-by-word data signal to serial-by-word data signal, and transmitting the serial-by-word data signal to control units connected in a multi-drop connection configuration or receiving the signals transmitted from the control units.An external control mode and an internal control mode in receiving the parallel-by-word data signal, a simulation mode, and the prevention of competing status between a write timing of the parallel-by-word data to a buffer memory and a read timing of the data for converting it to serial-by-word data are described.

Abstract: 2,5-Dideoxystreptamine is provided which is a new compound useful in the fermentative production of 5-deoxyneamine having useful antibacterial activity by culturing a microorganism. The production of 2,5-dideoxystreptamine is made by catalytic hydrogenation of 6,7-diaza-bicyclo[3.2.1]octane-2,4-diol which is also a new compound.